Correlation Between Astera Labs, and NervGen Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Astera Labs, and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astera Labs, and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astera Labs, Common and NervGen Pharma Corp, you can compare the effects of market volatilities on Astera Labs, and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astera Labs, with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astera Labs, and NervGen Pharma.

Diversification Opportunities for Astera Labs, and NervGen Pharma

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Astera and NervGen is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Astera Labs, Common and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Astera Labs, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astera Labs, Common are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Astera Labs, i.e., Astera Labs, and NervGen Pharma go up and down completely randomly.

Pair Corralation between Astera Labs, and NervGen Pharma

Given the investment horizon of 90 days Astera Labs, Common is expected to generate 1.27 times more return on investment than NervGen Pharma. However, Astera Labs, is 1.27 times more volatile than NervGen Pharma Corp. It trades about 0.24 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.08 per unit of risk. If you would invest  7,030  in Astera Labs, Common on August 25, 2024 and sell it today you would earn a total of  3,271  from holding Astera Labs, Common or generate 46.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Astera Labs, Common  vs.  NervGen Pharma Corp

 Performance 
       Timeline  
Astera Labs, Common 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Astera Labs, Common are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Astera Labs, sustained solid returns over the last few months and may actually be approaching a breakup point.
NervGen Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, NervGen Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Astera Labs, and NervGen Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Astera Labs, and NervGen Pharma

The main advantage of trading using opposite Astera Labs, and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astera Labs, position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.
The idea behind Astera Labs, Common and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets